How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
作者信息
Hien Doan Luong, Pham Brandon Huy, Nguyen Quan Dong
机构信息
Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, California, USA.
Pham Ngoc Thach University of Medicine, Saigon, Vietnam.
出版信息
J Ophthalmic Vis Res. 2020 Oct 25;15(4):442-445. doi: 10.18502/jovr.v15i4.7777. eCollection 2020 Oct-Dec.
Abstract
摘要
相似文献
1
How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
J Ophthalmic Vis Res. 2020 Oct 25;15(4):442-445. doi: 10.18502/jovr.v15i4.7777. eCollection 2020 Oct-Dec.
2
Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy.
J Ophthalmic Vis Res. 2020 Oct 25;15(4):459-469. doi: 10.18502/jovr.v15i4.7786. eCollection 2020 Oct-Dec.
3
Clinical spectrum of HLA-B27-associated ocular inflammation.
Nepal J Ophthalmol. 2022 Jul;14(28):116-134. doi: 10.3126/nepjoph.v14i2.50679.
4
Double trouble: a patient with both HLA-B27 anterior uveitis and HLA-A29 birdshot chorioretinitis.
J Ophthalmic Inflamm Infect. 2014 Dec;4(1):28. doi: 10.1186/s12348-014-0028-6. Epub 2014 Nov 26.
5
Clinical Spectrum of HLA-B27-associated Ocular Inflammation.
Ocul Immunol Inflamm. 2017 Aug;25(4):569-576. doi: 10.1080/09273948.2016.1185527. Epub 2016 Jul 18.
6
Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
Rom J Ophthalmol. 2018 Apr-Jun;62(2):114-122.
7
Outcomes of early and late immunomodulatory treatment in patients with HLA-B27-associated chronic uveitis.
Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):1000-5. doi: 10.1007/s00417-003-0789-3. Epub 2003 Nov 7.
8
Biologic Therapy for HLA-B27-associated Ocular Disorders.
Ocul Immunol Inflamm. 2017 Apr;25(2):169-178. doi: 10.1080/09273948.2016.1234625. Epub 2016 Oct 17.
9
Acute anterior uveitis and HLA-B27.
Surv Ophthalmol. 2005 Jul-Aug;50(4):364-88. doi: 10.1016/j.survophthal.2005.04.003.
10
Ocular Decompression Retinopathy after Cataract Surgery in HLA-B27 Associated Anterior Uveitis.
Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1977-1979. doi: 10.1080/09273948.2021.1912361. Epub 2021 Jul 9.
本文引用的文献
1
Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy.
J Ophthalmic Vis Res. 2020 Oct 25;15(4):459-469. doi: 10.18502/jovr.v15i4.7786. eCollection 2020 Oct-Dec.
2
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.
Pulmonology. 2021 Jan-Feb;27(1):52-66. doi: 10.1016/j.pulmoe.2020.07.003. Epub 2020 Jul 20.
3
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program.
Ophthalmology. 2020 Oct;127(10):1405-1415. doi: 10.1016/j.ophtha.2020.03.033. Epub 2020 Apr 3.
4
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.
Autoimmun Rev. 2020 Jul;19(7):102568. doi: 10.1016/j.autrev.2020.102568. Epub 2020 May 3.
5
Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.
Pediatr Rheumatol Online J. 2019 Nov 29;17(1):79. doi: 10.1186/s12969-019-0383-9.
6
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
JAMA. 2019 Sep 10;322(10):936-945. doi: 10.1001/jama.2019.12618.
7
Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU):: The Phase 2 SATURN Study.
Ophthalmology. 2019 Mar;126(3):428-437. doi: 10.1016/j.ophtha.2018.09.044. Epub 2018 Oct 11.
8
Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies.
Ophthalmology. 2018 Dec;125(12):1984-1993. doi: 10.1016/j.ophtha.2018.06.015. Epub 2018 Jul 27.
9
2018 update of the EULAR recommendations for the management of Behçet's syndrome.
Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.
10
Subcutaneous repository corticotropin gel for non-infectious panuveitis: Reappraisal of an old pharmacologic agent.
Am J Ophthalmol Case Rep. 2016 Sep 28;4:78-82. doi: 10.1016/j.ajoc.2016.09.004. eCollection 2016 Dec.
Zotero 插件